Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British Journal of Pharmacology

• Publication date

  2001-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0704327PMID 11606325PMCID PMC1573017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The fatty acid amide hydrolase (FAAH).

  2002cited by this paper
• Structure‐activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

  2001cited by this paper
• Vanilloid receptor 길항제의 분자설계 및 합성

  2001cited by this paper
• Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

  2001cited by this paper
• Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.

  2001cited by this paper
• The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK‐1

  2001cited by this paper
• Characterization of palmitoylethanolamide transport in mouse Neuro‐2a neuroblastoma and rat RBL‐2H3 basophilic leukaemia cells: comparison with anandamide

  2001cited by this paper
• Local Application of Capsaicin into the Draining Lymph Nodes Attenuates Expression of Adjuvant-Induced Arthritis

  2000cited by this paper
• Impaired nociception and pain sensation in mice lacking the capsaicin receptor.

  2000cited by this paper
• Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity

  2000cited by this paper
• The fatty acid amide hydrolase (FAAH).

  2000cited by this paper
• The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

  2000influential reference
• The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes.

  2000cited by this paper
• New perspectives on enigmatic vanilloid receptors.

  2000cited by this paper
• Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia

  2000cited by this paper
• Cloning and functional expression of a human orthologue of rat vanilloid receptor‐1

  2000cited by this paper
• The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

  2000cited by this paper
• Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.

  2000cited by this paper
• Cannabimimetic fatty acid derivatives in cancer and inflammation.

  2000cited by this paper
• Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.

  2000influential reference
• Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.

  2000cited by this paper
• Synthesis of a primary metabolite of cannabidiol.

  2000cited by this paper
• Vanilloid (Capsaicin) receptors and mechanisms.

  1999cited by this paper
• Recent Advantages in Cannabinoid Research

  1999cited by this paper
• Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

  1999cited by this paper
• The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?

  1999cited by this paper
• Pharmacology of cannabinoid receptor ligands.

  1999cited by this paper
• Structure-activity relationships of anandamide, an endogenous cannabinoid ligand.

  1999influential reference
• Interactions between synthetic vanilloids and the endogenous cannabinoid system

  1998cited by this paper
• The cloned capsaicin receptor integrates multiple pain-producing stimuli.

  1998cited by this paper
• Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

  1998cited by this paper
• Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity.

  1998cited by this paper
• Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells.

  1998cited by this paper
• Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells

  1998cited by this paper
• Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity.

  1998cited by this paper
• Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes*

  1997cited by this paper
• Pharmacology of cannabinoid CB1 and CB2 receptors.

  1997cited by this paper
• Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids.

  1996cited by this paper
• Convulsions and death induced in rats by Tween 80 are prevented by capsaicin.

  1996cited by this paper
• Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

  1996influential reference
• ()--Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl Cyclase (*)

  1996cited by this paper
• Formation and inactivation of endogenous cannabinoid anandamide in central neurons

  1994influential reference
• Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.

  1994cited by this paper
• A novel probe for the cannabinoid receptor.

  1992cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons.

  1991cited by this paper
• Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.

  1990cited by this paper
• Effect of cannabidiol on cytochrome P-450 isozymes.

  1989cited by this paper
• Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons.

  1989cited by this paper
• Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs.

  1989cited by this paper
• Stereochemical effects of 11-OH-Δ8-THC-dimethylheptyl in mice and dogs

  1989cited by this paper
• Enantiomeric cannabinoids: stereospecificity of psychotropic activity

  1988cited by this paper
• Structure-anticonvulsant activity relationships of cannabidiol analogs.

  1987cited by this paper
• Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

  1986cited by this paper
• Prostaglandins and cannabis XIV. Tolerance to the stimulatory actions of cannabinoids on arachidonate metabolism.

  1985cited by this paper
• Boron trifluoride etherate on alumina ― a modified Lewis acid reagent. An improved synthesis of cannabidiol

  1985cited by this paper
• Anticonvulsant effects of the (-) and (+)isomers of cannabidiol and their dimethylheptyl homologs.

  1982cited by this paper
• Antiepileptic Potential of Cannabidiol Analogs

  1981cited by this paper
• The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish.

  1967cited by this paper
• The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish.

  1967cited by this paper
• Hashish. I. The structure of cannabidiol.

  1963cited by this paper

• Antiseizure Effects of Cannabidiol in Combination With Cannabigerol in the Maximal Electroshock Seizure Model

  2026cites this paper
• Sex-specific association between low oral doses of cannabidiol (CBD) and plasma concentration of anandamide (AEA), N-palmitoylethanolamine (PEA) and N-oleoylethanolamine (OEA) in healthy occasional cannabis users

  2026cites this paper
• Repeated administration of cannabidiol decreases splenic lymphocyte subset numbers in rats

  2026cites this paper
• Update of the statement on safety of cannabidiol as a novel food

  2026cites this paper
• Cannabidiol suppresses emergency MDSCs generation by disturbing EEF1B2-mediated C/EBPβ protein synthesis in colorectal adenomas

  2026cites this paper
• Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies.

  2026cites this paper
• THC and CBD Induce Heme Oxygenase-1-Dependent Cell Death and Trigger Mitochondrial Dysfunction in Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells

  2026cites this paper
• Cannabidiol mitigates high-fat-diet-induced early-stage inflammation in two adipose tissue fat depots of Wistar rats

  2026influential citation
• Cannabichromene attenuates fracture pain but impairs bone repair in a murine tibial fracture model.

  2026cites this paper
• Cannabidiol improves L-DOPA-induced dyskinesia and modulates neuroinflammation and the endocannabinoid, endovanilloid and nitrergic systems.

  2025cites this paper
• TRPV receptors in pain research: Bridging molecular mechanisms to clinical treatments

  2025cites this paper
• CANNABIDIOL MODULATES CLASSICAL AND NON-CLASSICAL HLA EXPRESSION IN HUMAN CHORIOCARCINOMA CELL LINE

  2025cites this paper
• Recreational drugs repurposed for medicinal use—cannabis

  2025cites this paper
• Potentiation of endocannabinoid signaling alleviates depressive-like behavior in diabetic mice

  2025cites this paper
• NON-PSYCHOACTIVE CANNABIS EXTRACT PROMOTES EXTINCTION AND REDUCES REINSTATEMENT BY PRIMING DOSE IN SMOKED COCAINE-INDUCED CONDITIONED PLACE PREFERENCE.

  2025cites this paper
• Stereoselective Synthesis of Cannabidiol and its Unnatural Enantiomer to Evaluate Anxiolytic‐Like Properties and Memory Interactions

  2025cites this paper
• CBD and the 5-HT1A receptor: A medicinal and pharmacological review.

  2025cites this paper
• Cannabidiol Reduces D1 and D2 Medium Spiny Neuron Excitability in the Nucleus Accumbens Core

  2025cites this paper
• The Pharmacological Profile of Plant-Derived Cannabinoids In Vitro.

  2025cites this paper
• The pro-, but not anti-nociceptive effects of Cannabidiol depend on Trpa1b in larval Zebrafish

  2025cites this paper
• Cannabis sativa extracts reduce inclusion formation in a cell model of alpha-synuclein aggregation.

  2025cites this paper
• In Vivo and In Vitro Crosstalk Among CBD, Aβ, and Endocannabinoid System Enzymes and Receptors.

  2025cites this paper
• Effects and safety of a CBD-rich Cannabis sativa oil in knee osteoarthritis: a double-blind, randomized, placebo-controlled trial – CANOA – cannabis for osteoarthritis

  2025cites this paper
• Cannabidiol and Parkinson's disease: Investigating receptor interactions and their therapeutic implications.

  2025cites this paper
• Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

  2025cites this paper
• Bubble Perfusion Brain Slice Culture with Single-Droplet Stimulus Delivery in a 3D Printed Microfluidic Device

  2025cites this paper
• Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells

  2025cites this paper
• Retinal pharmacodynamic and pharmacokinetics profile of cannabidiol in an in vivo model of retinal excitotoxicity.

  2025cites this paper
• UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Cancer Pain

  2025cites this paper
• Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (-) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives

  2025cites this paper
• New insights into the crosstalk between endocannabinoids and sphingosine-1-phosphate

  2025cites this paper
• Molecular Mechanisms of the Endocannabinoid System with a Focus on Reproductive Physiology and the Cannabinoid Impact on Fertility

  2025cites this paper
• Cannabidiol alleviates methamphetamine addiction via targeting ATP5A1 and modulating the ATP–ADO–A1R signaling pathway

  2025cites this paper
• Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD

  2025cites this paper
• TRPV1-expressing neurons in the dorsal raphe nucleus are activated by self or others' pain.

  2025cites this paper
• A novel cannabidiol:tetramethylpyrazine cocrystal (CBD:TMP, ART12.11) improves the efficacy and bioavailability of cannabidiol in reducing stress-induced depressive and anxiety symptoms.

  2025cites this paper
• Effects of Different Cannabinoid Formulations on Anxiety-Related Disorders, and Tourette Syndrome: A Systematic Review and Meta-Analysis

  2025cites this paper
• Cannabidiol attenuates diet-induced metabolic endotoxemia, neuroinflammation, and anxiety-like behaviors in male aged rats.

  2025cites this paper
• A Novel Liposomal Palmitoylethanolamide (PEA) with Enhanced Gastrointestinal Permeating Properties

  2025cites this paper
• The Therapeutic Potential of Cannabidiol in Skin Conditions

  2025cites this paper
• Can Endocannabinoids Explain CBD-Mediated Reduction in Blood Pressure? Insights from a Randomized, Placebo-Controlled, Crossover Trial.

  2025cites this paper
• The Effect of Cannabidiol on Nociceptive Behaviour and the Endocannabinoid System in an Incisional Wound Model

  2025cites this paper
• Adolescent cannabidiol treatment produces antidepressant-like effects without compromising long-term cognition in rats

  2025cites this paper
• Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy

  2025cites this paper
• Cannabidiol reverses microglia activation and loss of parvalbumin interneurons and perineuronal nets in a mouse model of schizophrenia.

  2025cites this paper
• Beyond the hype: a comprehensive exploration of CBD’s biological impacts and mechanisms of action

  2025cites this paper
• Cannabidiol as an immune modulator: A comprehensive review

  2025cites this paper
• Cannabidiol as a Neuroprotective Agent in Acrylamide‐Induced Neurotoxicity: Effects on Oxidative Stress, Inflammation, and Cholinergic Function in Male Mice

  2025cites this paper
• Cannabinoids and the endocannabinoid system in the regulation of cytochrome P450 metabolic activity-a review

  2025cites this paper
• Retrospective Observations from a Pilot Study on the Feasibility and Safety of Medication Reduction or Withdrawal in Children with Autism Spectrum Disorder Taking Cannabidiol-Rich Oil

  2025cites this paper
• Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor.

  2025cites this paper
• Evaluation of Cannabidiol Oil’s Effects on Sedation, Behavioral Responses to Handling, and Nociceptive Thresholds in Healthy Cats

  2025cites this paper
• Carvone derived cannabidiol enantiomers as novel anticonvulsants

  2025cites this paper
• Cannabinoid agonist, WIN 55,212-2, increases in vivo paired-pulse facilitation, long-term potentiation, and Arc expression in the dentate gyrus.

  2025cites this paper
• Cannabinoid-based Pharmacology for the Management of Substance Use Disorders.

  2025cites this paper
• Chiral recognition of CIAC001 isomers in regulating pyruvate kinase M2 and mitigating neuroinflammation.

  2025cites this paper
• Utilization of Cannabidiol in Post-Organ-Transplant Care

  2025cites this paper
• Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders.

  2025cites this paper
• From barbiturates to ganaxolone: The importance of chirality in drug development and in understanding the actions of old and new antiseizure medications.

  2025cites this paper
• Nanoemulsions with cannabidiol reduced autistic-like behaviors and reversed decreased hippocampus viable cells and cerebral cortex neuronal death in a prenatal valproic acid rat model.

  2025cites this paper
• Comparison between Cannabidiol and Fluoxetine effects on chronic neuropathic pain and depression comorbid in rats

  2025cites this paper
• Repeated administration of cannabidiol decreases splenic lymphocyte numbers in rats: involvement of CB2 receptors

  2025influential citation
• Efficacy of non-psychotropic Cannabis sativa L. standardized extracts in a model of intestinal inflammation

  2025cites this paper
• Post-weaning exposure to cannabidiol disrupts testicular cytoarchitecture and sperm quality in mice.

  2025cites this paper
• The Potential Use of Cannabidiol in the Treatment of Opioid Use Disorder: A Systematic Review

  2025cites this paper
• Cannabidiol dose dependently reduces alcohol intake in mice via a non‐5‐HT1A receptor mechanism: Exploration of other potential receptor targets

  2025cites this paper
• Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder

  2025cites this paper
• Cannabidiol for Orofacial and Upper-Quarter Pain: A Systematic Evaluation of Therapeutic Potential

  2025cites this paper
• A cannabidiol (CBD) lipid-based nanoemulsion induces anxiolytic- and panicolytic-like effects and increases FosB/deltaFosB immunoreactivity in serotonergic cells of the dorsal raphe.

  2025cites this paper
• Emerging Insights into the Pathogenic Mechanisms of Dravet Syndrome

  2025cites this paper
• Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism

  2024cites this paper
• Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders

  2024cites this paper
• Effects of cannabinoids use in temporomandibular disorders: a scoping review

  2024cites this paper
• The Role of Cannabinoids and the Endocannabinoid System in the Treatment and Regulation of Nausea and Vomiting.

  2024cites this paper
• Cannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels.

  2024cites this paper
• Medicinal Cannabis and the Intestinal Microbiome

  2024cites this paper
• Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review

  2024cites this paper
• Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice.

  2024cites this paper
• Stereoisomers of cannabidiols and their pharmacological activities - A potentially novel direction for cannabinoids.

  2024cites this paper
• A cautionary tale of paradox and false positives in cannabidiol research

  2024cites this paper
• CBD’s potential impact on Parkinson’s disease: An updated overview

  2024influential citation
• "Weeding out" violence? Translational perspectives on the neuropsychobiological links between cannabis and aggression.

  2024cites this paper
• Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus)

  2024cites this paper
• Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5R59X knock‐in mice

  2024cites this paper
• Pharmacotherapeutic strategies for the treatment of anorexia nervosa – novel targets to break a vicious cycle

  2024cites this paper
• A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors

  2024influential citation
• Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication

  2024cites this paper
• Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

  2024cites this paper
• Cutaneous targets for topical pain medications in patients with neuropathic pain: individual differential expression of biomarkers supports the need for personalized medicine

  2024cites this paper
• Cannabidiol: metabolism and clinical efficacy in epileptic patients

  2024cites this paper
• Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples

  2024cites this paper
• Oral delivery of cannabidiol: Revealing the formulation and absorption challenges

  2024cites this paper
• Cannabidiol Disrupts Mitochondrial Respiration and Metabolism and Dysregulates Trophoblast Cell Differentiation

  2024cites this paper
• A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders

  2024cites this paper
• Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity

  2024cites this paper
• The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex® - A Cannabis-derived Spray.

  2024cites this paper
• Cannabidiol improves maternal obesity-induced behavioral, neuroinflammatory and neurochemical dysfunctions in the juvenile offspring.

  2024cites this paper
• Cannabidiol ameliorates PTSD-like symptoms by inhibiting neuroinflammation through its action on CB2 receptors in the brain of male mice.

  2024cites this paper
• A Review of Sturge–Weber Syndrome Brain Involvement, Cannabidiol Treatment and Molecular Pathways

  2024cites this paper
• Cannabidiol and brain function: current knowledge and future perspectives

  2024cites this paper